ARCHIVES

FDA Guidance for Public Comment at Advisory Committee Meetings

This article is from The Cancer Letter archive.

Vol. 36 No. 45 | December 10, 2010

Download PDF Visit The Full Archive

Related Articles

ACS Prostate Cancer Recommendations Move Forward

August 7, 1992

FDA Commissioner Holds Up IND While Reviewing Toxicology Guidelines

August 14, 1981

NCI Offers Coded Serum Panels

May 28, 1982

Funding opportunities listed.

May 7, 2004

Zaltrap Price Cut In Half Effective Immediately

November 8, 2012

NY Attorney General Subpoenaes Amgen, J&J Over ESA Promotion.

May 25, 2007